$MNDY

Rosen Law Firm sues monday.com for allegedly concealing decelerating growth and extended sales cycles during a six-month period. Lead plaintiff deadline: May 11, 2026.

Rosen Law Firm files securities class action against $HTGC alleging false statements on valuations and due diligence. Lead plaintiff deadline: May 19, 2026.

Rosen Law Firm filed a securities class action against Aldeyra Therapeutics for alleged false statements. Affected investors must act by May 29, 2026 to become lead plaintiffs.

Rosen Law Firm files securities fraud class action against Corcept Therapeutics, alleging misrepresentation of relacorilant drug trial data. Lead plaintiff deadline: April 21, 2026.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue expansion and growth prospects from September 2025 to February 2026.

Rosen Law Firm urges monday.com investors to meet May 2026 deadline in securities fraud lawsuit alleging false growth claims.

monday.com faces class action alleging materially false statements about revenue expansion and growth prospects from September 2025 to February 2026.

Robbins Geller files class action against monday.com ($MNDY) alleging false revenue projections. Stock plunged 21% after company withdrew 2027 guidance.

Class action lawsuit filed against monday.com alleging securities fraud over false revenue statements and concealed growth deceleration during September 2025-February 2026 period.

monday.com sued for securities fraud over false growth projections; stock fell 21% on Feb. 9, 2026. Robbins Geller pursuing class action for defrauded investors.

Rosen Law Firm urges $MNDY investors to join class action lawsuit alleging false revenue guidance. Lead plaintiff deadline set for May 11, 2026.

Class action lawsuit alleges monday.com made false statements about revenue growth and sales cycles between September 2025 and February 2026, claiming investor harm.

Pomerantz Law Firm sues monday.com over guidance misses and abandoned $1.8B revenue target. Investors have until May 11, 2026, to join class action.

Schall Law Firm files securities fraud class action against $MNDY for allegedly misrepresenting revenue outlook and customer growth prospects.

Class action lawsuit filed against monday.com alleging false revenue and growth statements from September 2025 to February 2026. Investors urged to participate in suit.

Monday.com stock down 46% YTD despite analyst $128 price target. Strong 2025 results offset by cautious 2026 guidance amid AI uncertainty and weak SMB demand.

monday.com faces class action lawsuit alleging false growth projections during 2025-2026 period. Stock fell 21% after company abandoned $1.8B 2027 revenue target.

Palantir reports 70% revenue growth and 79% EPS growth with 137% commercial surge, though 100x P/E valuation leaves limited room for error amid recent 26% pullback.

Whetstone Capital fully exits monday.com position worth $15.3M amid SaaS sector decline. Stock down 76.8% as AI competition pressures legacy software platforms.

Tech giants spend $400B on AI infrastructure, creating winners with strong balance sheets and losers burdened by debt in this capital-intensive race.